To study the ophthalmic co-morbidities and post- COVID ophthalmic complications in mild to moderate COVID positive patients. This was a questionnaire based prospective longitudinal study conducted between August 2020 and December 2020. In the first phase, an ophthalmologist in personal protective equipment (PPE) physically visited the patients and a pre-designed structured questionnaire regarding any ophthalmic complaints was filled and scoring was done later. In the second phase, the patients were telephonically interviewed after 3-6 months of their discharge from the hospital, regarding the development of ocular symptoms for which they needed to consult an ophthalmologist and the treatment taken was noted. 9% of the total 77 patients included in the study reported severe symptoms (scores between 17-24/24). On comparing the mean questionnaire scores (out of 24) it was seen that more severe ophthalmic complaints were seen in patients aged >= 50 years than <50 years (11.35 vs 5.75, p<0.05), moderate category than mild category patients (11.70 vs 3.63, p<0.05), patients with systemic co-morbidities than those who had none (11.48 vs 4.04, p<0.05) and in patients who later needed to consult an ophthalmologist due to development of one or more complications than those who did not.(13.27 vs 6.63, p<0.05).Post- COVID complications were seen in 27 patients (35%). They included progression of pre-existing ocular disease like cataract, glaucoma, diabetic and hypertensive retinopathy, and new diagnosis of diabetic and hypertensive retinopathy and HCQ- related maculopathy. Ocular co-morbidities should be looked for in every COVID patient. Those at higher risk of developing complications, should undergo a detailed ophthalmic examination after they are discharged from the isolation wards. Hospitals need to work on capacity building and/or look for alternatives, like telemedicine, to ensure timely eye care to all patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.